Clinical Study
Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer
Figure 4
Kaplan-Meier estimate of overall survival among NSCLC patients showing different intensities of reaction with 14F7 Mab (, Log rank test).